Information For Authors
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
AIMS & SCOPES
Network and Systems Medicine is the premier open access, peer-reviewed journal focused on interdisciplinary approaches to exploiting the power of big data by applying systems biology and network medicine. Network and Systems Medicine yields major breakthroughs towards mechanism-based re-definitions of diseases for high-precision diagnostics and treatments.
Network and Systems Medicine publishes basic science, translational, and clinical research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor.
To avoid delays, please be sure to read all of the instructions below before submitting your paper.
All manuscripts must be submitted online using the Manuscript Central system, via the following URL:
All authors will need to have an account created for Network and Systems Medicine in Manuscript Central. For technical assistance or questions, please click here.
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title.
USE OF ENGLISH LANGUAGE
All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Network and Systems Medicine. For authors whose native language is not English, we suggest using a service that will aid in the translation and rewriting of material into correct and proper English usage. The Publisher offers this service with a subsidy from the author prior to official submission. For more information, please contact: Editing@liebertpub.com It is important to note that employing the use of the Publisher’s service is not required, and using it does not guarantee acceptance of any paper. All submissions are subject to peer review.
MANUSCRIPT TYPES AND WORD LIMITS
Word limits do not include the title, abstract, authors and affiliations, keywords, figure legends, tables, acknowledgements, authorship confirmation statement, author disclosure statements, acknowledgments, or references. Exceptions to the limitations set herein are permissible at the discretion of the Editor(s).
The Journal publishes basic science, translational, and clinical research in the form of the following article types:
Original Research Articles are full-length descriptions of original research in all fields of scientific, technical, and biomedical research. The investigation may focus on basic science, clinical outcomes, or applications.
Word limit: 3,000 words
350 words or less
Comprehensive Reviews are appraisals of research and clinical trials in fields of current interest. While these are subject to the same review process as other papers, authors are encouraged to speculate about future promise of new procedures and techniques. Unsolicited reviews are welcome.
Word limit: 5,000 words
350 words or less
Mini-reviews are brief summaries of developments in fast-moving areas of biomedical research, and must be must be based on published articles.
Word limit: 2,500 words
300 words or less
Rapid Communications are intended for the accelerated publication of cutting-edge, groundbreaking biomedical findings
Word limit: 1,500 words
200 words or less
Brief Reports are descriptions of completed findings that have met the criteria of biomedical research and peer review, but do not qualify as full original paper.
Word limit: 1,500 words
250 words or less
Technical Reports briefly and succinctly describe improvements or helpful modifications in current procedures.
Word limit: 2,000 words
Abstract: Structured or Unstructured
200 words or less
Hypothesis Articles: Original essays which explore theoretical aspects of biomedical research with a clear view toward eventual biomedical implications.
Word limit: 3,000 words
350 words or less
Perspectives are representative of an opinion about an area of the field or a direction of research.
Word limits: 2,000 words
250 words or less
Literature Reviews: Reviews of a topical area of research relevant to science, discussing the work of multiple research groups.
Word limit: 1,500 words.
200 words or less
Letters to the Editor: A forum for presentation of preliminary clinical results, advances in technology, and case reports. In addition, letters extending, contesting, challenging, or disputing claims advanced in previous publications are encouraged and will be submitted to the original authors for comment.
Word limit: 1,200 words with no more than four references and one figure or table.
Abstract: Not applicable
KEYWORDS (Areas of Expertise to be used for peer review)
While uploading your manuscript files, you will be asked to select 4-6 keywords from the drop-down list of pre-selected terms to facilitate the peer review process. These keywords will assist in the selection of skilled reviewers in the field for the purposes of peer review.
PRESENTATION OF MANUSCRIPT
(Please follow these requirements and sequence:)
Tips for creating an effective title for your manuscript:
- Titles should be direct and clearly convey the content and purpose of the research
- The editorial office suggests that a title be less than 12-15 words, though not a requirement
- Select important keywords related to the subject
- Avoid using specific regions/locations if possible
- Do not use brand names
THE TITLE PAGE of your submission must be included as part of your main text document (not as a separate file) and must include the following items:
- The complete title of the article;
- All contributing authors’ full names, complete affiliation and mailing address, full contact information (telephone and e-mail address);
- A brief running title of no more than 45 characters, including spaces;
- Denotation of the corresponding author and his/her complete contact information including address and email address;
- Three (3) to six (6) manuscript keywords.c
cManuscript Keywords (search terms)
On the title page of the manuscript, include a minimum of three (3), maximum of six (6), search terms that will aid in the discoverability of the article in indexing services and search engines. These terms may or may not be different from the terms you selected for the peer review process and areas of expertise. You will be asked to retype these search terms in the submission form when uploading your manuscript. These keywords will be included in the published article.
Authorship Confirmation Statement
On a separate page within the manuscript file, following the title page, include a paragraph detailing each listed authors’ contributions to and responsibilities for the manuscript. This text should also contain a statement that all co-authors have reviewed and approved of the manuscript prior to submission. Lastly, include a confirmation statement that the manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere.
Author Disclosure Statementsd
On a separate page within the manuscript file, following the Authorship Confirmation Statement page, include any financial conflicts of interest, actual or potential, for each listed author on the submission. If no conflicts exist, the authors must state, “No competing financial interests exist.” Articles submitted without Author Disclosure Statements will be un-submitted so that a statement may be added.
dSee the JOURNAL POLICIES section below for more information, or visit the ICJME website at www.icmje.org
Requirements for Abstract:
- The abstract must be in Word and part of the main text file
- Prepare abstract on a separate page to be included after the title page and the Authorship Confirmation Statement page
- Abstract word limits are as noted in Manuscript Types section
- Do not use proprietary or trade names in the title or abstract
- References are not permitted in the abstract
- The use of the first person should be avoided
- Clearly summarize the results and conclusions of the work
- Name all files in English and use only alphanumeric characters. Do not use symbols, dots, lines, or dashes
- Figure files names should be formatted with first author’s last name and the figure number. (Ex: SmithFig1)
Main Text File:
After the title page, abstract, Authorship Confirmation, and Author Disclosure Statements, prepare the remainder of the text following this sequence of sections:
- Materials and Methods
- Appendices (if applicable)
- Prepare each figure as individual .TIFF or .EPS file
- Do NOT submit figures in Word, PowerPoint, PDF, Bitmap, .JPEG, or Excel.
- Line illustrations must be submitted at 900 DPI.
- Halftones and color should be submitted at a minimum of 300 dpi.
- Color art must be saved as CMYK - not RGB. (N.B., If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
- Black and white art must be submitted as grayscale – not RGB.
Additional Information on Converting Figure Files
Converting Word or Excel files: The best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:
- All files should be scanned at 100% size
- Minimum of 300 dpi
- Final color mode: CMYK
- Save file as: .tif, .tiff, or .eps
For more direction on how to convert a Power Point slide to acceptable format go to: www.liebertpub.com/MEDIA/pdf/ppconvert.pdf
Color Publication Costs: No additional charge.
- Prepare and save each table in individual .doc or .docx files.
- Do not include tables in the main manuscript text file.
- Do not embed tables within the text.
- Include a table number and a title for each supplied table.
- Use Arabic numerals to number tables.
- Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
- Define all acronyms used within the body of the table in table footnotes.
- All other types of table footnotes should be designated using superscript letters, not symbols.
- Name all table files in English and use only alphanumeric characters. Do not use symbols, dots, lines, or dashes.
- Table file names should be formatted with first author’s last name and the figure number. (Ex: SmithTable1)
- Upload individual table file under the “Table” file designation.
When appropriate, we encourage the judicious use of online-only supplemental information. All information/data in the supplementary information should be referred to in the manuscript proper, including reference to specific tables and figures in the supplementary material. Upload supplementary tables, figures, and legends as separate files, either as “supplementary file” or “supplementary file for review only.” Other supporting data and text are appropriate for the supplementary section. NOTE: Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)
Order of Files During Submission
Upload manuscript files to our system in the following order:
- Manuscript/Main text file
- Figure Legends
- Supplementary files
Note: There is a total limit of 200 MB per submission.
Reference List Preparation. Prepare a numbered (not alphabetical) reference list, in the order of citation within text and double spaced, at the end of the text of the manuscript (do not upload the reference list as a separate file). See formatting examples below.
In-Text Citations. Cite all references appearing in the reference list in numerical order, as superscripted numbers (no parentheses) and outside sentence punctuation.
If more than three authors are listed on an article, list the first three authors then use et al. (not italic) after the third author’s name. Abbreviations of journal titles in reference section should follow the style of MEDLINE (http://www.ncbi.nlm.nih.gov/nlmcatalog). Include the full article title, year of publication, volume, and inclusive page range. If work is in press, state the journal title in which it is to be published, and include "in press" in parenthesis in place of a volume and page range. When references to unpublished sources/correspondence are used, supply the researcher’s name and date.
For Users of EndNote: At this time, Network and Systems Medicine does not yet have a template in EndNote, but you may use the journal, Human Gene Therapy, as a substitute as it follows the same reference style. Go to www.EndNote.com, search for “Human Gene Therapy,” and download the template. Please note that the publisher of Network and Systems Medicine does not provide technical support for EndNote. If you have questions or experience any difficulties, click on the Support tab at www.EndNote.com for assistance.
Liang Y, Kelemen A. Computational dynamic approaches for temporal omics data with applications to systems medicine. BioData Min. 2017;10:20. doi: 10.1186/s13040-017-0140-x.
Davies K. The $1,000 Genome: The Revolution in DNA Sequencing and the New Era of Personalized Medicine. New York, NY: Free Press. 2010.
Chapter in a Book:
Hagland M. Transformed roles for a transformed healthcare system: Where do clinical informaticists fit in now? In: Healthcare Information Management Systems: Cases, Strategies, and Solutions, 4e. (Weaver CA, Ball MJ, Kim GR, Kiel JM; eds). Springer, New York, NY. 2015; pp. 189–198.
Website: Please follow this structure for website references, including capitalization and punctuation:
List author (if available) and/or page name/title. Website article title. Provide website URL. Include last accessed date.
Conference Proceedings: Please follow this structure for Conference Proceeding references, including capitalization and punctuation:
List all Authors’ (or) Editors’ names (last name first, followed by first and middle initials). Conference title. Date of conference. Location of conference. City of publisher: Publisher; Year of publication. Complete number of pages in proceedings book.
OPEN ACCESS AND COPYRIGHT
All articles published in Network and Systems Medicine are made freely and permanently accessible online upon publication without access or subscription charges, embargo periods, or user registration.
Once a manuscript is accepted for publication, the author(s) will sign an Open Access Licensing Agreement. Authors of articles published in the Journal will be the copyright holders and a Creative Commons CC BY license will be applied. For more information, please read the full Creative Commons CC BY license.
For authors who are US government employees or are prevented from being copyright holders for similar reasons, Liebert Open Access can accommodate non-standard copyright. Please contact firstname.lastname@example.org.
POST-ACCEPTANCE / PRODUCTION
All accepted manuscripts will go through copyediting, typesetting, figure sizing and placement, author proofing, corrections, revisions (from corrected proofs), online-ahead-of-print release, and lastly, issue assignment. Depending on the length and complexity of any accepted submission, these steps take an average of 3-6 weeks from acceptance.
Page proofs will be sent to the (one) corresponding author as designated when the manuscript was submitted. It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof. The Publisher will not accept corrections from multiple authors.
AUTHOR RESPONSE TO GALLEY PROOF
The corresponding author must accept full responsibility to return corrected galley proof within 72 hours of receipt. Only corrections directly related to errors in typesetting will be allowed. Other changes will have to be approved by the Editor. If the corresponding author does not respond within 72 hours of receipt of the galley proof, the manuscript may be delayed in the publication schedule, or published as is, at the discretion of the Editor and Publisher. If the corresponding author expects to be unavailable during the time the manuscript is in production, the publisher should be provided with an alternate contact.
Mary Ann Liebert, Inc. offers a reprint service for those who require professionally produced copies of a CC-BY licensed-article. Contact: email@example.com to obtain a quote. Please include the article DOI, title, number of reprint copies, and delivery destination.
Network and Systems Medicine generally follows Committee on Publication Ethics (COPE; https://publicationethics.org/ and International Committee of Journal Medical Editors (ICJME; http://www.icmje.org/) guidelines.
Network and Systems Medicine is a single-blinded peer-reviewed journal. All submissions are subject to peer review. A minimum of two skilled reviewers in the area of study will be selected to assess the scientific basis of the submission. After sufficient reviews are received, the Editor and/or Associate Editors will determine if the paper should move forward to revision, or if the paper is unacceptable for publication.
Time in Review: The journal strives to maintain a short, but thorough peer-review process. The average time in review is 21 days.
Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process. Sharing a manuscript in whole or in part, outside the scope of what is necessary for assessment, is impermissible prior to the manuscript’s official publication date.
Sharing of Materials Policy
Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review.
Papers Authored by the Editor-in-Chief and/or Associate Editors
The Editor-in-Chief and Associate Editors will recuse themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest.
Internal Review Board Approvals/Waivers (as described and defined on the World Medical Association’s website; www.wma.net)
When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.
If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.
STUDY DESIGN AND ETHICS
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The Journal does not provide a generic patient release form.
Any identifying information should not be included in descriptions or images unless the information is essential for scientific purposes and the patient (or parent/guardian) gives expressed informed consent – in writing – for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript prior to submission. Authors should disclose to these patients whether any potential identifiable material might be available in any form, either online or print as a result of publication. Any non-essential patient-identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. Masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain statements that such changes do not distort scientific meaning.
In keeping with patients’ rights of privacy, the Journal does not require the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests they have received and archived written patient consent.
Ethical Treatment of Animals
All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles, and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.
PATIENT RELEASE INFORMATION
All authors are encouraged to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
There is a limit of 20 authors permitted on a single submission.
Definition of Authorship
Authorship, as defined by the International Committee of Medical Journal Editors, is based on the following criteria1:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper. This designation should be determined at the time of submission. All communications* regarding any submission, except for copyright forms, will be directed only to the corresponding author.
*All authors may receive marketing emails.
Working Groups/Team Authorship
Working Groups or Teams may be listed in the manuscript byline, but the entire listing of names should be included in the acknowledgment section of the manuscript. Do not list the names in a footnote on the title page.
Variations of Authorship
It is permissible to list two authors as co-first authors. Include an asterisk (*) next to the authors’ names who are considered as first authors. Include a corresponding footnote, using the asterisk, on the title page that reads, “These authors contributed equally to this work and are considered to be co-first authors.”
Contributors who meet fewer than all four of the above criteria for authorship should not be listed as authors, but they should be acknowledged.
Changes in Authorship
Changes in authorship after acceptance are generally discouraged, but the editorial leadership recognizes that in certain circumstances, it is required. The Journal’s policy is as follows:
1. A request to alter authorship must be made in writing from the corresponding author to the Journal's Editor-in-Chief, with a detailed explanation for the request, and the names and affiliations of the authors requiring addition and/or deletion.
2. Authorship may be altered after acceptance of a paper with the written approval of all authors named on the manuscript, as well as the individual(s) being added and/or deleted. The Publisher can provide a form for this, if needed.
3. Upon receipt of the request and all written approvals of all involved parties, the Editor-in-Chief will consider the request, render a decision, and notify the corresponding author.
4. There is a one-year post-publication statute of limitation on requests for alterations in authorship.
***Important Note about Author Listing***
It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. All authors’ names should be entered into Manuscript Central.
AUTHOR DISCLOSURE STATEMENTS
1. Competing Interests. A competing interest exists when an individual (or the individual’s institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
2. Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
3. Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
4. Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
5. Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.
SELF-CITATION AND SELF-PLAGIARISM
Network and Systems Medicine is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to acceptance. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content compared to work previously published by authors, self-plagiarism can infringe upon a publisher’s copyright. To avoid plagiarism, be sure to cite all published works.
ARTICLE PUBLICATION CHARGES (APC)
Network and Systems Medicine is a fully open access journal. The cost of maintaining and publishing the Journal are covered by Article Processing Charges (APC). Visit the Journal’s Open Access Policy tab for more information about the Journal’s APC. There are no color figure charges associated with this Journal.
RESEARCH FUNDER COMPLIANCE (FundRef)
Upon submission of a manuscript, you will have an opportunity to enter funding/grant information. If funding information is entered correctly, the publisher will deposit the funding acknowledgements from the article as part of the standard metadata. The entered information should include funder names, funder IDs (if available), and associated grant numbers. (See https://www.crossref.org/services/funder-registry/ for a listing of more than 13,000 international funding agencies.)
Our open access publishing solutions allows you to easily comply with the open access policies of your institution, government and funding body. If you are employed or funded by the National Institute of Health (NIH), the Wellcome Trust, Research Councils UK (RCUK) or Howard Hughes Medical Institute (HHMI), you can find more information below.
HHMI and NIH Public Access Policy – In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final paginated version of the published article to PubMed Central (PMC) on behalf of the authors with no embargo. Authors need not take any action. This service is provided at no additional charge.
Wellcome Trust and Research Councils UK (RUCK) Policies - Network and Systems Medicine is compliant with both policies because it is a fully open access journal and publishes under the Creative Commons Attribution (CC BY) license. Publication in Journal allows authors to automatically comply with both funder policies. Article publication charges (APC) will be covered by the Wellcome Trust or RUCK.
REUSE OF MATERIAL PUBLISHED IN NETWORK AND SYSTEMS MEDICINE
Network and Systems Medicine publishes articles under the Creative Commons Attribution license. Users can read, download, copy, distribute, print, search, or link to the full texts of the articles in this Journal without requesting prior permission from the Publisher or the author.
PERMISSION TO REUSE PREVIOUSLY PUBLISHED MATERIAL FROM OTHER SOURCES
When reproducing or adapting any previously published copyrighted material including figures or tables, the author(s) must obtain written permission from the original publisher/copyright holder and retain it for retrieval upon request. The publication from which the figure or table is taken must be listed in the reference list and correctly cited in the text or figure/table legend(s). Finally, a footnote to a reprinted/adapted figure or table should read, “Reprinted(/adapted) by permission from Reference 123.” The Journal does not keep a record of granted permissions to reuse or adapt copyrighted material, so be sure to preserve the correspondence.
DEFINITIONS OF SCIENTIFIC MISCONDUCT
Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).
Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:
- Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
- Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.
- Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
- Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
- Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
- Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
- Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
- Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.
- Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.
RESPONDING TO ALLEGATIONS OF POSSIBLE MISCONDUCT
The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.
When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.
Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.
If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.
All allegations will be kept confidential.
Network and Systems Medicine is owned by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801; Tel: 914-740-2100; Email: Info@liebertpub.com; Website: www.liebertpub.com/
Systems Medicine is a journal of broad interest that has been launched to overcome unnecessary barriers to the immediate availability and use of research.
Benefits of publishing in Systems Medicine:
- High visibility, immediate and unrestricted online access to published articles
- Rigorous peer review
- Easy compliance with open access mandates
- Authors retain copyright
- Highly indexed – citation tracking and inclusion in bibliographic databases
- Targeted email marketing
The article publication charge (APC) for Systems Medicine is $2,000.00 USD for accepted articles.
Copyright and Licensing
Systems Medicine publishes articles under the liberal CC-BY license. This means that articles can be freely redistributed and reused by the author and others as long as the article is properly cited. Published articles in Systems Medicine can be deposited immediately into an online repository or social network without an embargo. Systems Medicine articles can be emailed to colleagues, printed, archived in a collection, included in course-packs, and distributed without restrictions. Please read the full Creative Commons license for further information.
APC waiver requests are handled on an individual basis. Authors may contact us directly at firstname.lastname@example.org to discuss a fee reduction or waiver.
Systems Medicine is fully compliant with NIH-, HHMI-, Wellcome Trust-, RCUK-, and major funder open access policies.
Mary Ann Liebert, Inc. will deposit all NIH-funded articles published in Systems Medicine to PubMed Central (PMC) upon online publication without an embargo period. Our workflow ensures compliance with the NIH Public Access Policy which mandates that NIH-funded authors submit their research article to PMC, or have their peer-reviewed author accepted manuscript submitted on their behalf, at point of acceptance by a journal.
*Please note that PubMed Central (PMC), not the Publisher, has sole control over when the paper is made live on PMC.
Publishing in Open Access Journals
There are no archiving restrictions for open access articles published under creative commons licenses. Author manuscripts and the final published version of any article published in Systems Medicine can be archived in a repository, preprint server, or shared on a research network without an embargo.
European Cooperation in Science and Technology (COST), Action CA15120 OpenMultiMed, and Italian Association for Systems Medicine and Healthcare (ASSIMSS)